FDA Import Refusal 799-6671732-3/11/9 — Aurobindo Pharma USA Inc
The FDA refused shipment 799-6671732-3/11/9 from Aurobindo Pharma USA Inc (United States) on Jan 10, 2022. The refused product falls under Drugs and Biologics — SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jan 10, 2022
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61NDA78 SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT)
- Charges
- 75